Skip to main content
Clinical Trials/NCT02143700
NCT02143700
Unknown
Not Applicable

Clinical Profile and Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients

Universidad de Granada1 site in 1 country60 target enrollmentApril 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Universidad de Granada
Enrollment
60
Locations
1
Primary Endpoint
Cognitive impairment
Last Updated
11 years ago

Overview

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a chronic condition involving an impairment in functionality and in the execution of activities of daily life. The hypothesis of this study is to examine the relationship between cognitive status and clinical profile (respiratory, sleep quality, nutritional status) in patients with chronic obstructive pulmonary disease in two different moments: exacerbation or stable situation.

Detailed Description

Chronic obstructive pulmonary disease is a pathology with a systemic impact with a progressive evolution that is characterized by the presence of chronic airflow obstruction. Patients with COPD may have problems with cognitive functioning, either globally or in single cognitive domains, such as information processing, attention and concentration, memory, executive functioning and self-regulation. Several studies have determined the prevalence of cognitive impairment in COPD compared to healthy control subjects, reaching very high levels, 36% of COPD patients with mild cognitive impairment compared with 12 % non- COPD subjects.

Registry
clinicaltrials.gov
Start Date
April 2014
End Date
December 2014
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marie Carmen Valenza

Assisstant professor

Universidad de Granada

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of chronic obstructive pulmonary disease with exacerbation or stable.
  • Signed written consent.
  • Medical approval for inclusion

Exclusion Criteria

  • Heart disease.
  • Neurological patients.
  • Severe cognitive impairment in order not to complete the assessment.

Outcomes

Primary Outcomes

Cognitive impairment

Time Frame: Baseline

The cognitive impairment will be measured using the Montreal Cognitive Assessment. The Montreal Cognitive Assessment is a test designed as a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.

Secondary Outcomes

  • Sleep quality(Baseline)
  • Activity monitoring(Baseline)
  • Nutritional state(Baseline)
  • Quality of life(Baseline)
  • Cough(Baseline)
  • Comorbidities(Baseline)
  • Anxiety and depression(Baseline)
  • Cognitive flexibility(Baseline)
  • Forced vital capacity(Baseline)
  • Forced expiratory volume in the first second(Baseline)

Study Sites (1)

Loading locations...

Similar Trials